| Antibiotic-resistant bacteria show widespread collateral sensitivity to antimicrobial peptides V Lázár, A Martins, R Spohn, L Daruka, G Grézal, G Fekete, M Számel, ... Nature microbiology 3 (6), 718-731, 2018 | 339 | 2018 |
| Integrated evolutionary analysis reveals antimicrobial peptides with limited resistance R Spohn, L Daruka, V Lázár, A Martins, F Vidovics, G Grézal, O Méhi, ... Nature communications 10 (1), 4538, 2019 | 267 | 2019 |
| Exercise training and calorie restriction influence the metabolic parameters in ovariectomized female rats A Pósa, R Szabó, K Kupai, A Csonka, Z Szalai, M Veszelka, S Török, ... Oxidative medicine and cellular longevity 2015 (1), 787063, 2015 | 58 | 2015 |
| Cotranslational protein assembly imposes evolutionary constraints on homomeric proteins E Natan, T Endoh, L Haim-Vilmovsky, T Flock, G Chalancon, JTS Hopper, ... Nature structural & molecular biology 25 (3), 279-288, 2018 | 44 | 2018 |
| Dual action of the PN159/KLAL/MAP peptide: Increase of drug penetration across caco-2 intestinal barrier model by modulation of tight junctions and plasma membrane permeability A Bocsik, I Gróf, L Kiss, F Ötvös, O Zsíros, L Daruka, L Fülöp, M Vastag, ... Pharmaceutics 11 (2), 73, 2019 | 42 | 2019 |
| Rapid evolution of reduced susceptibility against a balanced dual-targeting antibiotic through stepping-stone mutations P Szili, G Draskovits, T Révész, F Bogár, D Balogh, T Martinek, L Daruka, ... Antimicrobial agents and chemotherapy 63 (9), 10.1128/aac. 00207-19, 2019 | 40 | 2019 |
| Chemical-genetic profiling reveals limited cross-resistance between antimicrobial peptides with different modes of action B Kintses, PK Jangir, G Fekete, M Számel, O Méhi, R Spohn, L Daruka, ... Nature Communications 10 (1), 5731, 2019 | 33 | 2019 |
| Rational design of balanced dual-targeting antibiotics with limited resistance A Nyerges, T Tomašič, M Durcik, T Revesz, P Szili, G Draskovits, F Bogar, ... PLoS biology 18 (10), e3000819, 2020 | 27 | 2020 |
| New dual ATP-competitive inhibitors of bacterial DNA gyrase and topoisomerase IV active against ESKAPE pathogens M Durcik, Á Nyerges, Ž Skok, DG Skledar, J Trontelj, N Zidar, J Ilaš, ... European journal of medicinal chemistry 213, 113200, 2021 | 24 | 2021 |
| New metabolic influencer on oxytocin release: the ghrelin R Szabó, R Ménesi, A H. Molnár, Z Szalai, L Daruka, G Tóth, J Gardi, ... Molecules 24 (4), 735, 2019 | 14 | 2019 |
| Antibiotic-resistant bacteria show widespread collateral sensitivity to antimicrobial peptides. Nat Microbiol 3: 718–731 V Lázár, A Martins, R Spohn, L Daruka, G Grézal, G Fekete, M Számel, ... | 14 | 2018 |
| Csörgo† B R Spohn, L Daruka, V Lázár, A Martins, F Vidovics, G Grézal, O Méhi, ... Györkei Á, Bódi Z, Faragó A, Bodai L, Földesi I, Kata D, Maróti G, Pap B …, 2019 | 7 | 2019 |
| Rationally designed foldameric adjuvants enhance antibiotic efficacy via promoting membrane hyperpolarization KN Bhaumik, A Hetényi, G Olajos, A Martins, R Spohn, L Németh, B Jojart, ... Molecular Systems Design & Engineering 7 (1), 21-33, 2022 | 5 | 2022 |
| Proteome-wide landscape of solubility limits in a bacterial cell Á Györkei, L Daruka, D Balogh, E Őszi, Z Magyar, B Szappanos, G Fekete, ... Scientific Reports 12 (1), 6547, 2022 | 4 | 2022 |
| Chemical-genetic profiling reveals cross-resistance and collateral sensitivity between antimicrobial peptides B Kintses, PK Jangir, G Fekete, M Számel, O Méhi, R Spohn, L Daruka, ... bioRxiv, 542548, 2019 | 4 | 2019 |
| Antibiotics of the future are prone to resistance in gram-negative pathogens L Daruka, MS Czikkely, P Szili, Z Farkas, D Balogh, E Maharramov, TH Vu, ... bioRxiv, 2023.07. 23.550022, 2023 | 2 | 2023 |
| Antibiotic usage promotes the evolution of resistance against gepotidacin, a novel multi-targeting drug P Szili, G Draskovits, T Révész, F Bogar, D Balogh, T Martinek, L Daruka, ... bioRxiv, 495630, 2018 | 2 | 2018 |
| Genomic surveillance as a scalable framework for precision phage therapy against antibiotic-resistant pathogens M Koncz, T Stirling, HH Mehdi, O Méhi, B Eszenyi, A Asbóth, G Apjok, ... Cell, 2024 | | 2024 |
| Az antimikrobiális peptidekkel szemben kialakuló rezisztencia rendszer szintű vizsgálata L Daruka szte, 2024 | | 2024 |
| New N-phenylpyrrolamide inhibitors of DNA gyrase with improved antibacterial activity AE Cotman, F Fulgheri, M Piga, P Peršolja, DB Tiz, Ž Skok, M Durcik, ... RSC advances 14 (39), 28423-28454, 2024 | | 2024 |
